TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
DHR

Danaher Corporation

Healthcare · Diagnostics & Research

221.60$ +0.2% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

Danaher Corporation (DHR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 1,534 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow DHR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
1,672 1,619 1,739 1,417 1,513 2,019 1,299 1,338 1,662 2,117 1,322 1,534 6,635
554 493 586 580 591 595 591 611 622 522 627 659 2,430
92 26 60 87 84 57 61 91 83 146 58 93 380
140 – – – – – – – – – – – –
-151 -242 -57 -216 -99 174 -403 -395 -67 155 -147 69 10
365 402 291 287 298 516 245 248 292 371 237 269 1,169
-1,064 -6,017 -321 -360 -606 -694 -242 -258 -312 -384 -249 -10,147 -11,092
199 200 177 200 196 195 194 229 229 226 226 283 964
51 -38 0.0 -4,530 -640 -809 -1,078 -1,064 -1,985 -25 -9.0 -885 -2,904
2,603 – – – -14 -696 1.0 2.0 -477 1,519 309 8,485 9,836
2,443 -2,246 -133 -5,715 -845 -1,692 -1,255 -247 -2,724 1,265 46 7,273 5,860
3,702 -6,413 1,167 -4,657 253 -549 -85 964 -782 3,097 1,086 -1,353 2,048
1,307 1,217 1,448 1,130 1,215 1,503 1,054 1,090 1,370 1,746 1,085 1,265 5,466

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?